Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
14 Fév 2025
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
Equity Research
14 Fév 2025
Equity Research KlaraBo, Q4 2024: Better management results and large property value gains
Equity Research
KlaraBo
14 Fév 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Equity Research
Nosa Plugs
13 Fév 2025
Equity research CDON Q4 2024: First impression
Equity Research
CDON
13 Fév 2025
Equity Research GIAB, Q4 2024: Lack of liquidity due to weak sales
Equity Research
11 Fév 2025
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
10 Fév 2025
Equity Research ALM Equity, Q4 2024: Improved outlook for housing development in 2025
Equity Research
ALM Equity
06 Fév 2025
Equity Research GIAB, Q4 2024: Positive impact expected from savings programmes
Equity Research
04 Fév 2025
Equity Research KlaraBo, Q4 2024: 43% discount to NAV despite acquisitions and growth
Equity Research
KlaraBo
03 Fév 2025
Equity Research Ecoclime, Q4 2024: Cash boost for Evertherm investment
Equity Research
20 Jan 2025
Equity research Viva Wine Group: Positive profitability trend should continue in Q4 2024
Equity Research
Viva Wine Group
20 Jan 2025
Equity research CDON: CDON segment likely a drag on Q4 growth
Equity Research
CDON
15 Jan 2025
Equity research Teneo AI: Preliminary figures above expectations
Equity Research
Teneo AI
08 Jan 2025
Equity Research, Zinzino: Blow away sales should lift profits
Equity Research
Zinzino
19 Déc 2024
Equity Research Nosa Plugs: Drug Delivery patent submitted
Equity Research
Nosa Plugs
11 Déc 2024
Investment Case Immunovia: Promising clinical data and incoming triggers
Equity Research
Immunovia
10 Déc 2024
Analyse Lokotech: Ny rammeavtale for forhåndsbestilling av Hashblades
Equity Research
Lokotech
10 Déc 2024
Equity Research Lokotech: Important Pre-Order agreement in place
Equity Research
Lokotech
05 Déc 2024
Equity Research Svenska Aerogel, Q3 2024: Supplier agreements could boost revenues
Equity Research
Svenska Aerogel
04 Déc 2024
Analyse Lokotech Group AS: Kryptocase nærmer seg kommersialisering
Equity Research
Lokotech
1
…
8
9
10
11
12
…
64